Beclin 1 has a key role in the initiation of autophagy, a process of self-cannibalism in which cytoplasmic constituents are sequestered and targeted for lysosomal degradation. In a recent issue of Cell Death & Disease, Wirawan et al. report the significant finding that caspases can cleave Beclin 1, thereby destroying its pro-autophagic activity. Moreover, the C-terminal fragment of Beclin 1 that results from this cleavage acquires a new function and can amplify mitochondrion-mediated apoptosis. Of note, the BH3 domain of Beclin 1 remains within the N-terminal fragment, which has no detectable pro-apoptotic activity. These findings provide important insights into the molecular cross talk between autophagy and apoptosis.
Macroautophagy (here referred as to autophagy) is a process in which a cell engulfs cytoplasmic material within a vacuole (an autophagosome) and delivers it to the lysosome for degradation. The first step of autophagosome formation requires the activation of the class III phosphatidyl inositol-3-kinase that depends on the formation of a multiprotein complex including Beclin 1 (the mammalian ortholog of yeast Atg6) (Xie and Klionsky, 2007; Maiuri et al., 2007a) . Beclin 1 has been identified originally as a Bcl-2-interacting protein, and Bcl-2 (as well as its homology Bcl-X L ) indeed inhibits the autophagic function of Beclin 1 (Sinha and Levine, 2008) .
Recently, it has been shown that Beclin 1 possesses a Bcl-2 homology 3 domain (BH3-only), which is necessary for its binding to the BH3 receptor domain of Bcl-2 or Bcl-X L . Mutations of either the BH3-only domain within Beclin 1 or the BH3 receptor domain within Bcl-2 or Bcl-X L disrupt the Beclin 1/Bcl-2 complex, resulting in the stimulation of autophagy (Maiuri et al., 2007b; Sinha and Levine, 2008) . Although BH3-only proteins of the Bcl-2 family are well-known inducers of apoptosis and autophagy, Beclin 1 fails to induce apoptosis even when it is overtly overexpressed and stimulates autophagy. This is most likely due to its ineffective role in the inactivation of the anti-apoptotic function of the Bcl-2 family (Boya and Kroemer, 2009; Ciechomska et al., 2009) . Otherwise, Beclin 1 offers cytoprotection against several inducers of apoptosis including starvation, which suggests an antiapoptotic function of this protein (Sinha and Levine, 2008; Boya and Kroemer, 2009 ). These findings raise the following questions: Is there any autoinhibitory domain within Beclin 1 that represses its potential pro-apoptotic function? And do apoptosis and pro-apoptotic molecules modulate the function of Beclin 1? Wirawan et al. (2010) examined these burning questions in a cellular model system in which the withdrawal of the obligatory growth factor interleukin-3 induces apoptotic cell death that is preceded by a phase of increased autophagy. They showed that Beclin 1 and class III phosphatidyl inositol-3-kinase, two components of the autophagy-inducing complex, are direct substrates of caspases. The cleavage of Beclin 1 and class III phosphatidyl inositol-3-kinase by caspases was observed in response to different inducers of the intrinsic (mitochondrial) and extrinsic (death receptor-mediated) pathways of apoptosis and occurred in several distinct cell types. Thus, Beclin 1 and class III phosphatidyl inositol-3-kinase are novel substrates of caspases 3, 7 and 8, highlighting a possible cross talk between autophagy and apoptosis. In accordance with this finding, recently it has been shown that Bax overexpression, which activates the intrinsic pathway of apoptosis, causes caspase-mediated cleavage of Beclin 1 at D149 (Luo and Rubinsztein, 2009 ). Moreover, Cho et al. (2009) showed that TRAIL, a death receptor ligand, triggers the caspase-mediated cleavage of Beclin 1. Our own unpublished data confirm that nutrient deprivation and oxidative stress can trigger caspasedependent cleavage of Beclin 1. Wirawan et al. (2010) reported that the N-terminal (Beclin 1-N, aa 1-133) and C-terminal (Beclin 1-C, aa 150-450) cleavage products of Beclin 1 failed to induce autophagy in conditions, in which the positive control, full-length Beclin 1 clearly stimulated an autophagic response. Moreover, analysis of the subcellular localization of Beclin 1 and its cleavage products revealed the nuclear accumulation of the N-terminal Beclin 1 fragment, contrasting with the mitochondrial localization of its C-terminal fragment and the diffuse cytoplasmic distribution of full-length Beclin 1. Thus, the loss of proautophagic activity of Beclin 1 fragments might be explained, at least in part, by their mislocalization (as compared to full-length Beclin 1).
More importantly, Wirawan et al. (2010) proved that Beclin 1, once cleaved by caspases, can acquire a new apoptosis-promoting function. Indeed, Beclin 1-C translocated from the cytosol to mitochondria and amplified apoptosis induced by interleukin-3 deprivation. In a cell free system, isolated mitochondria released pro-apoptotic factors on exposure to recombinant Beclin 1-C protein, suggesting a mechanism through which Beclin 1-C might favor the apoptotic process. Surprisingly, Beclin 1-N, which contains the BH3-only domain, failed to promote apoptosis in conditions in which the Beclin 1-C fragment stimulated cell killing. How can this paradox be explained? One possible explanation would be the presence of a regulatory element within the N-terminal domain of Beclin 1 that represses the potential pro-apoptotic function of this protein. The removal of this autoinhibitory domain in the N terminus would then enable the Beclin 1-C fragment to induce apoptosis. Another possible explanation would be that the formation of the new N terminus that results from caspase cleavage (and that logically is contained in Beclin 1-C) reveals novel pro-apoptotic properties. Additional studies must explore the relationship between Beclin 1 structure and its cryptic pro-apoptotic function.
How does Beclin 1-C act on mitochondria to cause the permeabilization of their outer membrane? Generally, BH3-only proteins exert their apoptogenic role through their physical interaction with and functional inactivation of Bcl-2 proteins (Bcl-2, Bcl-X L , Mcl-1) at mitochondria. However, there are multiple examples of proteins, such as Cofilin or Nur 77 (Chua et al., 2003 ; Thompson and Winoto, 2008) , that lack discernible BH3-only domains, yet promote cell death through their capacity to translocate to mitochondria and to favor their permeabilization. Clearly, the mechanism through which Beclin 1-C performs its apoptosis-promoting function is not yet understood and should be examined in future studies. Interestingly, Beclin 1-C was able to promote apoptosis when cells were subjected to interleukin-3 withdrawal, yet failed to kill cells in the absence of additional lethal stimuli. This suggests that Beclin 1-C acts in conjunction with other regulatory factors to enhance apoptosis. Further experiments are required to identify the regulatory factors that might facilitate the recruitment of Beclin 1-C to mitochondria and/or amplify its local permeabilizing action (Figure 1) .
Caspases are cysteine aspartyl proteases that have a cardinal role in apoptotic cell death. Activation Figure 1 Proposed model of apoptosis regulation by Beclin 1 and its fragments. Apoptotic stimuli that activate death receptor-and mitochondria-mediated cell death pathway cause activation of autophagy, a pro-survival mechanism. During sustained exposure to apoptotic stimuli, caspase-mediated cleavage of Beclin 1 generates fragments (Beclin 1-N) and (Beclin 1-C) that lose their ability to induce autophagy. The Beclin 1-C fragment translocates to mitochondria and sensitizes cells to apoptotic signals. This represents an amplifying loop mechanism for inducing massive apoptotic cell death. X and Y are yet unidentified factors that may facilitate the recruitment of Beclin 1-C to mitochondria and enhance its local permeabilizing activity, respectively.
Cross talk between apoptosis and autophagy M Djavaheri-Mergny et al of caspases induces the cleavage of a large number of proteins through direct or indirect mechanisms that result in their inactivation or occasionally in their activation (typically due to the removal of regulatory domains) (Yi and Yuan, 2009 ). Besides Beclin 1, Atg5 (that is required for the elongation of autophagosomes) and Atg4D (that mediates the proteolytic maturation of Atg8) are autophagy-related proteins that can be cleaved during apoptosis. When apoptosis occurs, calpain-mediated cleavage of Atg5 reportedly generates a truncated protein that interacts with Bcl-2 proteins at mitochondria to facilitate the induction of apoptotic death (Yousefi et al., 2006) . Although apoptosisassociated cleavage of Beclin 1 and Atg5 inactivates autophagy, the cleavage of Atg4D by caspase-3 generates a fragment with increased autophagy activity. This fragment has a cytotoxic effect that is not caused by enhanced autophagy but correlates with its recruitment to mitochondria (Betin and Lane, 2009) . Thus, the apoptosis-associated cleavage of Atg4D, similar to that of Beclin 1 and Atg5, may amplify the apoptotic response through the mitochondria pathway.
Another link between autophagy and apoptosis has been reported recently by Lee et al. (2009) , who showed that Flip (Flice inhibitory protein), which is a prototypic inhibitor of death receptor-mediated apoptosis (and represses caspase-8 activation) can suppress autophagy. Both cellular Flip and viral Flip orthologs compete with LC3 for Atg3 binding, thereby preventing Atg3-mediated autophagosome elongation. Interestingly, mutational analyses indicated that this anti-autophagic role of Flip can be dissociated from its anti-apoptotic and nuclear factor-kB-stimulatory activities. Therefore, as seen for Bcl-2, Flip inhibits autophagy through a direct interaction with essential autophagy-relevant proteins .
The aforementioned examples emphasize the role of apoptosis regulatory factors in the regulation of several steps of the autophagy process. Conversely, Bcl-2 and Flip are two anti-apoptotic proteins that inhibit autophagy by forming complexes with Beclin 1 and Atg3, respectively. Alternatively, the apoptosis-associated cleavage of Beclin 1, Atg5 and Atg4D can result in the abolition of cytoprotective autophagy (at least in the case of Beclin 1 and Atg5) and result in the formation of protein fragments that facilitate the execution of the apoptotic program.
The most important finding of the study by Wirawan et al. (2010) is the novel pro-apoptotic function of Beclin 1 that becomes apparent after its cleavage by caspases. Thus, besides its tumor-suppressor function, Beclin 1 might sensitize cells to pro-apoptotic inducing chemotherapies. This suggests that the absence of Beclin 1 expression, which correlates with clinical outcome, at least in some tumors (Maiuri et al., 2009) , might constitute a novel mechanism of chemotherapy resistance.
Conflict of interest
The authors declare no conflict of interest.
